2024/07/16 13:33:14 | |
---|---|
Price | |
0.0107 EUR | |
Difference | 78.33% (0.00) |
ISIN | BE0974280126 |
Symbol | BIOS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | BEL 20 INDEX |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 0.0056 EUR |
High | 0.0107 EUR |
Low | 0.0056 EUR |
Close (prev. day) | 0.006 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings | ||
2024/04/26 | Global Equity Ratings |
2024/07/16 13:33:14 | |
---|---|
Price | |
0.0107 EUR | |
Difference | 78.33% (0.00) |
ISIN | BE0974280126 |
Symbol | BIOS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3 EUR |
Benchmark | BEL 20 INDEX |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 0.0056 EUR |
High | 0.0107 EUR |
Low | 0.0056 EUR |
Close (prev. day) | 0.006 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -77.23% | -81.86% | -99.57% |
Perf (abs.) | -0.04 | -0.05 | -2.48 |
Beta | 0.31 | 0.01 | 0.42 |
Volatility | 503.41 | 438.26 | 260.44 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.0090 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.0134 EUR (9,690) |
Ø price 100 days | Ø volume 100 days (pcs.) | 0.0155 EUR (3,707) |
Ø price 250 days | Ø volume 250 days (pcs.) | 0.0335 EUR (1,509) |
YTD High | date | 0.0614 EUR (2024/01/03) |
YTD Low | date | 0.0054 EUR (2024/07/12) |
52 Weeks High | date | 0.1595 EUR (2023/09/22) |
52 Weeks Low | date | 0.0054 EUR (2024/07/12) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Stuttgart | 2024/07/16 | 13:33 | 0.0107 EUR | 0.00 | 5 |
London Stock Exchange | 2021/01/04 | 15:05 | 2.6200 EUR | 0.00 | 1 |
Frankfurt | 2024/07/16 | 08:02 | 0.006 EUR | 0.00 | 1 |
Euronext Brussels | 2024/07/16 | 17:21 | 0.0125 EUR | 0.04 | 125 |
Berlin | 2024/07/16 | 21:50 | 0.0146 EUR | 0.00 | 19 |
BIOSENIC SA |
- - |
Bâtiment H bte 24, Rue Granbonpré 11 - 1435 Mont-Saint-Guibert |
Telefon: +32-49-309-73-66 |
Fax: + |
E-mail: info@biosenic.com |
BioSenic SA is a biotech company engaged in the development of clinical assets . The company was founded in 2006 and is headquartered in Mont-Saint-Guibert, Belgium. |
Miguel Forte | Chairman of Managing Board |
Anne Leselbaum | Member of Executive Committee |
Anne-Sophie Lebrun | Member of Executive Committee |
Anthony Ting | Member of Executive Committee |
Stefanos Theoharis | Member of Executive Committee |
Revital Rattenbach | Member of Supervisory Board |
Yves Sagot | Member of Supervisory Board |
Jean Stephenne | Member of Supervisory Board |
Jean-François Rax | Member of Supervisory Board |
Jean-Luc Vandebroek | Member of Supervisory Board |
Véronique Pomi-Schneiter | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer